Epilepsy

Staff

Dr Hannah Cock BSc MRCP MD - Senior Lecturer and Honorary Consultant
Neurologist; Principal Investigator hannahrc@sgul.ac.uk
Personal website www.hannahrc.com

Dr Tim Von Oertzen - Consultant Neurologist & Honorary Senior Lecturer

Dr Dora Lozsadi - Consultant Neurologist (starting Aug 2010)

Marie Synnott Wells - Epilepsy Nurse specialist/Research Nurse 

Amanda Reeve - Assistant Epilepsy Nurse 

Secretary/contact via - adult.epilepsy@stgeorges.nhs.uk

Mr Simon Stapleton - Neurosurgeon

Geoff Marshall - Clinical Neuropsychologist

Dr Niruj Agrawal - Neuropsychiatrist
niruj.agrawal@swlstg-tr.nhs.uk
n.agrawal@sgul.ac.uk

The research group moved from the Institute of Neurology, London to SGUL in September 2003, as part of a new joint Trust and medical school initiative to develop epilepsy.  The research group has received funding from the Wellcome Trust, Brain Research Trust, Epilepsy Research Foundation, St Georges Charitable Foundation, and pharmaceutical sponsors. A 2nd NHS Epilepsy Consultant, and Clinical Nurse Specialist in epilepsy started in January 2004, and the clinical service is now well established, including a developing epilepsy surgery program. 

Current Work

NEST - Non Epileptic Seizure Treatment (see http://www.shef.ac.uk/nest/research.html  http://www.shef.ac.uk/nest/research.html). Collaborator/co-applicant and site principle investigator for NEST 2 and 3. Funder: NIHR research for patient benefit.

Industry sponsored clinical trials: Site principle or co-investigator for a number of industry sponsored clinical trials currently running at St George's Epilepsy Clinic, facilitated by an epilepsy research nurse, and the support of the newly established dedicated Clinical Trials Facility at St George's.

Established Status Epilepticus Treatment Trial: This is a project in development, seeking funding for a multicentre, international adaptive pragmatic randomized controlled trial to compare newer alternatives (iv valproate or levetiracetam) to the current standard (fos)phenytoin where initial benzodiazepine treatment has failed.  The ESETT group which Hannah Cock leads includes internationally recognzied experts in epilepsy/status epilepticus, health economics, and emergency medicine, specifically including expertise in running randomized controlled trials in the emergency settings, including members of NETT (http://www.nett.umich.edu/nett/welcome) and the Sheffield CTU (http://www.sheffield.ac.uk/ctru/ ).  A parallel US-ESETT group, of which Hannah Cock is a member has also been established hoping to run a similar trial in the USA. Centres interested in participating if funding is gained are encouraged to contact Hannah Cock.  

Contact: hannahrc@sgul.ac.uk